Platelet function is the key cellular mechanism of primary hemostasis.
Platelet Function Test
The baseline quantitative platelet aggregation studies of all donors were performed as per manufacturer's instructions on a Chrono-log Lumi aggregometer (560VS, Chrono-Log Corp., Havertown, PA), which measures the turbidity of the plasma. Briefly, 500μl of PRP with a platelet count of about 250x10 3 All results were analyzed, and differences were calculated and compared between type A, type B, and controls using paired t-tests.
Results
Normal baseline platelet aggregation to ADP of seven type A and six type B normal blood donors was demonstrated. Following the incubation of their PRP with O plasma, platelet aggregation was significantly inhibited in comparison with NS by a mean of 41 and 22% for group A and B platelets, respectively (p≤0.005) and by 31 and 22%, respectively, in comparison with AB plasma (p≤0.005) (see Table 1 ).
Compared with the baseline platelet aggregation studies, no significant changes were detected in either type when incubated with NS. Figure 1 shows a representative example of platelet aggregation of a type A donor. Platelet aggregation following incubation with NS was 81%, which was not different from the baseline aggregation of 80% (not shown).
After incubation with O plasma (contains anti-A antibodies, titer of 1:1,024), aggregation dropped to 58% with inhibition of 29%. Platelet aggregation following incubation with AB plasma was normal at 75%.
An example of platelet aggregation of type B donor is shown in Figure 2 . Platelet aggregation with NS was 78%, which was also not different from baseline aggregation of 80%. Following a 10 minutes 
